Maximilian Huttasch

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Insulin resistance, not hepatic histological features, is the dominant correlate of insulin clearance in class 3 obesity.

Insulin resistance, not hepatic histological features, is the dominant correlate of insulin clearance in class 3 obesity.

Journal: Diabetes research and clinical practice
Published: June 23, 2026

Response to Comment on Huttasch et al. Increased Early Postprandial Glucagon Concentrations in Humans With Newly Diagnosed Type 2 Diabetes and Steatotic Liver Disease.

Response to Comment on Huttasch et al. Increased Early Postprandial Glucagon Concentrations in Humans With Newly Diagnosed Type 2 Diabetes and Steatotic Liver Disease.

Journal: Diabetes care
Published: June 22, 2026

Systemic Inflammation and Peripheral T Cell Responses Associate With Hepatic Energy Metabolism in Recent-Onset Type 1 Diabetes.

Systemic Inflammation and Peripheral T Cell Responses Associate With Hepatic Energy Metabolism in Recent-Onset Type 1 Diabetes.

Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: March 04, 2026

Increased Early Postprandial Glucagon Concentrations in Humans With Newly Diagnosed Type 2 Diabetes and Steatotic Liver Disease.

Increased Early Postprandial Glucagon Concentrations in Humans With Newly Diagnosed Type 2 Diabetes and Steatotic Liver Disease.

Journal: Diabetes care
Published: December 19, 2025

Cohort profile: The DIabetes and ST-segment Elevation Myocardial Infarction (DISTEMI) Study.

Cohort profile: The DIabetes and ST-segment Elevation Myocardial Infarction (DISTEMI) Study.

Journal: Cardiovascular diabetology
Published: November 25, 2025

Blood-flow restriction resistance training improves skeletal muscle mitochondrial capacity and cardiovascular risk factors in type 2 diabetes.

Blood-flow restriction resistance training improves skeletal muscle mitochondrial capacity and cardiovascular risk factors in type 2 diabetes.

Journal: Cell metabolism
Published: May 30, 2025

Liver lipid droplet cholesterol content is a key determinant of metabolic dysfunction-associated steatohepatitis.

Liver lipid droplet cholesterol content is a key determinant of metabolic dysfunction-associated steatohepatitis.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 01, 2025

Heterogeneity in clinically diagnosed type 1 diabetes: characterising a unique cohort with maintained C-peptide secretion in Ghana.

Heterogeneity in clinically diagnosed type 1 diabetes: characterising a unique cohort with maintained C-peptide secretion in Ghana.

Journal: Diabetologia
Published: April 25, 2025

Liver lipid droplet cholesterol content is a key determinant of metabolic dysfunction-associated steatohepatitis.

Liver lipid droplet cholesterol content is a key determinant of metabolic dysfunction-associated steatohepatitis.

Journal: bioRxiv : the preprint server for biology
Published: March 10, 2025

PNPLA3 gene variation modulates diet-induced improvement in liver lipid content in type 2 diabetes.

PNPLA3 gene variation modulates diet-induced improvement in liver lipid content in type 2 diabetes.

Journal: Clinical nutrition (Edinburgh, Scotland)
Published: February 23, 2025

BCG Vaccination-Associated Lower HbA1c and Increased CD25 Expression on CD8+ T Cells in Patients with Type 1 Diabetes in Ghana.

BCG Vaccination-Associated Lower HbA1c and Increased CD25 Expression on CD8+ T Cells in Patients with Type 1 Diabetes in Ghana.

Journal: Vaccines
Published: March 22, 2024

Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?

Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?

Journal: Metabolism: clinical and experimental
Published: August 29, 2023
Showing 1-12 of 14

Last Updated: 09/26/2026